Hydro-Seq enables contamination-free high-throughput single-cell RNA-sequencing for circulating tumor cells

[1]  Robbyn K. Anand,et al.  A Self-Digitization Dielectrophoretic (SD-DEP) Chip for High-Efficiency Single-Cell Capture, On-Demand Compartmentalization, and Downstream Nucleic Acid Analysis. , 2018, Angewandte Chemie.

[2]  C. Ariani,et al.  Finding the needle in the haystack , 2017, Nature Reviews Microbiology.

[3]  Hyeun Joong Yoon,et al.  High-Throughput Microfluidic Labyrinth for the Label-free Isolation of Circulating Tumor Cells. , 2017, Cell systems.

[4]  R. Matkowski,et al.  Molecular characterization and heterogeneity of circulating tumor cells in breast cancer , 2017, Breast Cancer Research and Treatment.

[5]  J. Fuxe,et al.  Epithelial‐mesenchymal transition in cancer metastasis through the lymphatic system , 2017, Molecular oncology.

[6]  J. C. Love,et al.  Seq-Well: portable, low-cost RNA sequencing of single cells at high throughput. , 2017, Nature methods.

[7]  Amy E Herr,et al.  Profiling protein expression in circulating tumour cells using microfluidic western blotting , 2017, Nature Communications.

[8]  J. C. Love,et al.  Seq-Well: A Portable, Low-Cost Platform for High-Throughput Single-Cell RNA-Seq of Low-Input Samples , 2017 .

[9]  C. Sotiriou,et al.  The Prognostic Role of Androgen Receptor in Patients with Early-Stage Breast Cancer: A Meta-analysis of Clinical and Gene Expression Data , 2016, Clinical Cancer Research.

[10]  Kevin K. Chang,et al.  Platelet-Derived Growth Factor Receptor Alpha Promotes Cancer Stem-Like Cell Phenotypes in Sarcomas Including Metastasis and Chemotherapy Resistance , 2016 .

[11]  E. Yoon,et al.  Scaling and automation of a high-throughput single-cell-derived tumor sphere assay chip. , 2016, Lab on a chip.

[12]  Sridhar Ramaswamy,et al.  HER2 expression identifies dynamic functional states within circulating breast cancer cells , 2016, Nature.

[13]  D. Heymann,et al.  Circulating Tumor Cells: A Review of Non-EpCAM-Based Approaches for Cell Enrichment and Isolation. , 2016, Clinical chemistry.

[14]  Stefanie S Jeffrey,et al.  Circulating tumor cell technologies , 2016, Molecular oncology.

[15]  D. Haber,et al.  Single-Cell Analysis of Circulating Tumor Cells as a Window into Tumor Heterogeneity. , 2016, Cold Spring Harbor symposia on quantitative biology.

[16]  M. Nivsarkar,et al.  CD90 a potential cancer stem cell marker and a therapeutic target. , 2016, Cancer biomarkers : section A of Disease markers.

[17]  A. S. Salinas Sánchez,et al.  Liquid biopsy in cancer. , 2016, Actas urologicas espanolas.

[18]  Panagiota Arampatzi,et al.  Common stemness regulators of embryonic and cancer stem cells. , 2015, World journal of stem cells.

[19]  Sridhar Ramaswamy,et al.  RNA-Seq of single prostate CTCs implicates noncanonical Wnt signaling in antiandrogen resistance , 2015, Science.

[20]  S. Takayama,et al.  Recent developments in multiplexing techniques for immunohistochemistry , 2015, Expert review of molecular diagnostics.

[21]  Eshel Ben-Jacob,et al.  Implications of the Hybrid Epithelial/Mesenchymal Phenotype in Metastasis , 2015, Front. Oncol..

[22]  Allon M. Klein,et al.  Droplet Barcoding for Single-Cell Transcriptomics Applied to Embryonic Stem Cells , 2015, Cell.

[23]  Evan Z. Macosko,et al.  Highly Parallel Genome-wide Expression Profiling of Individual Cells Using Nanoliter Droplets , 2015, Cell.

[24]  R. Sánchez-Martín,et al.  miRNA in situ hybridization in circulating tumor cells - MishCTC , 2015, Scientific Reports.

[25]  Genevieve Housman,et al.  EMT and tumor metastasis , 2015, Clinical and Translational Medicine.

[26]  S. P. Fodor,et al.  Combinatorial labeling of single cells for gene expression cytometry , 2015, Science.

[27]  A. Regev,et al.  Spatial reconstruction of single-cell gene expression , 2015, Nature Biotechnology.

[28]  Chichung Wang,et al.  Multiplexed immunohistochemistry, imaging, and quantitation: a review, with an assessment of Tyramide signal amplification, multispectral imaging and multiplex analysis. , 2014, Methods.

[29]  Ben S. Wittner,et al.  Single-Cell RNA Sequencing Identifies Extracellular Matrix Gene Expression by Pancreatic Circulating Tumor Cells , 2014, Cell reports.

[30]  K. Handique,et al.  A novel microchannel-based device to capture and analyze circulating tumor cells (CTCs) of breast cancer , 2014, International journal of oncology.

[31]  Dong Wang,et al.  Breast Cancer Stem Cells Transition between Epithelial and Mesenchymal States Reflective of their Normal Counterparts , 2013, Stem cell reports.

[32]  Le Wang.  Comparison of clinicopathologic features and survival in young American women aged 18–39 years in different ethnic groups with breast cancer , 2014 .

[33]  Jing Yang,et al.  Epithelial–mesenchymal plasticity in carcinoma metastasis , 2013, Genes & development.

[34]  G. Jiang,et al.  Breast cancer adaptive resistance: HER2 and cancer stem cell repopulation in a heterogeneous tumor society , 2013, Journal of Cancer Research and Clinical Oncology.

[35]  Chunsheng Jiang,et al.  Microfluidics and circulating tumor cells. , 2013, The Journal of molecular diagnostics : JMD.

[36]  Sridhar Ramaswamy,et al.  Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition , 2013, Science.

[37]  Klaus Pantel,et al.  Circulating tumor cells: liquid biopsy of cancer. , 2013, Clinical chemistry.

[38]  T. Brabletz.  EMT and MET in metastasis: where are the cancer stem cells? , 2012, Cancer cell.

[39]  F. Bertucci,et al.  Mevalonate Metabolism Regulates Basal Breast Cancer Stem Cells and Is a Potential Therapeutic Target , 2012, Stem cells.

[40]  E. Elkord,et al.  Significance of CD44 and CD24 as Cancer Stem Cell Markers: An Enduring Ambiguity , 2012, Clinical & developmental immunology.

[41]  I. Tinhofer,et al.  Circulating tumour cells escape from EpCAM-based detection due to epithelial-to-mesenchymal transition , 2012, BMC Cancer.

[42]  Caroline Dive,et al.  Analysis of Circulating Tumor Cells in Patients with Non-small Cell Lung Cancer Using Epithelial Marker-Dependent and -Independent Approaches , 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[43]  André F. Vieira,et al.  Breast cancer stem cell markers CD44, CD24 and ALDH1: expression distribution within intrinsic molecular subtype , 2011, Journal of Clinical Pathology.

[44]  V. Karantza,et al.  Keratins in health and cancer: more than mere epithelial cell markers , 2011, Oncogene.

[45]  Patrick W. Lee,et al.  Aldehyde Dehydrogenase Activity of Breast Cancer Stem Cells Is Primarily Due To Isoform ALDH1A3 and Its Expression Is Predictive of Metastasis , 2011, Stem cells.

[46]  M. Cher,et al.  Circulating tumor cells: finding the needle in the haystack. , 2011, American journal of cancer research.

[47]  C. Harley,et al.  The telomerase inhibitor imetelstat depletes cancer stem cells in breast and pancreatic cancer cell lines. , 2010, Cancer research.

[48]  A. Onitilo,et al.  Breast Cancer Subtypes Based on ER/PR and Her2 Expression: Comparison of Clinicopathologic Features and Survival , 2009, Clinical Medicine & Research.

[49]  L. Terstappen,et al.  Characterization of circulating tumor cells by fluorescence in situ hybridization , 2009, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[50]  A. Onitilo,et al.  Breast Cancer Subtypes Based on ER/PR and Her2 Expression: Comparison of Clinicopathologic Features and Survival , 2009, Clinical Medicine & Research.

[51]  K. Pienta,et al.  Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer , 2008, Clinical Cancer Research.

[52]  Daniel Birnbaum,et al.  ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. , 2007, Cell stem cell.

[53]  Harikrishna Nakshatri,et al.  CD44+/CD24- breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis , 2006, Breast Cancer Research.

[54]  G. Berx,et al.  SIP1/ZEB2 induces EMT by repressing genes of different epithelial cell–cell junctions , 2005, Nucleic acids research.

[55]  Yoichi Matsuo,et al.  Activation of focal adhesion kinase enhances the adhesion and invasion of pancreatic cancer cells via extracellular signal-regulated kinase-1/2 signaling pathway activation , 2005, Molecular Cancer.

[56]  Junwei Yang,et al.  Role for integrin-linked kinase in mediating tubular epithelial to mesenchymal transition and renal interstitial fibrogenesis , 2003 .

[57]  M. Karin,et al.  AP-1 in cell proliferation and survival , 2001, Oncogene.